ASSESSMENT OF THE PHARMACOKINETIC INTERACTION BETWEEN FIMASARTAN AND LINAGLIPTIN IN HEALTHY VOLUNTEERS.

被引：0
|
作者：
Seong, S. [1 ]
Kang, W. [1 ]
Ohk, B. [1 ]
Kim, B. [1 ]
Gwon, M. -R. [1 ]
Cho, S. [1 ]
Lee, H. [1 ]
Yoon, Y. -R. [1 ]
机构：
[1] Kyungpook Natl Univ, Hosp Clin Trial Ctr, Daegu, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-098
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [21] Lack of pharmacokinetic interaction between aliskiren, a novel direct renin inhibitor, and celecoxib in healthy volunteers.
    Agarwal, A.
    Vaidyanathan, S.
    Dieterich, H. A.
    Yeh, C.
    Howard, D.
    Dole, W. P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S109 - S110
  • [22] LINAGLIPTIN, A NOVEL POTENT DPP-4 INHIBITOR, HAS NO PHARMACOKINETIC INTERACTIONS WITH GLYBURIDE IN HEALTHY VOLUNTEERS.
    Graefe-Mody, U.
    Rose, P.
    Ring, A.
    Zander, K.
    Iovino, M.
    Woerle, H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S30 - S30
  • [23] Evaluation of the pharmacokinetic interaction between the dipeptidyl peptidase-4 inhibitor linagliptin and pioglitazone in healthy volunteers
    Graefe-Mody, E. U.
    Jungnik, A.
    Ring, A.
    Woerle, H. J.
    Dugi, K. A.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (10) : 652 - 661
  • [24] Assessment of a Potential Pharmacokinetic Interaction between Nebivolol and Bupropion in Healthy Volunteers
    Gheldiu, Ana-Maria
    Popa, Adina
    Neag, Maria
    Muntean, Dana
    Bocsan, Corina
    Buzoianu, Anca
    Vlase, Laurian
    Tomuta, Ioan
    Briciu, Corina
    [J]. PHARMACOLOGY, 2016, 98 (3-4) : 190 - 198
  • [25] ABSENCE OF MUTUAL PHARMACOKINETIC INTERACTIONS BETWEEN CILOSTAZOL AND PROBUCOL IN HEALTHY VOLUNTEERS.
    Kim, K. P.
    Kim, B. H.
    Kim, T. E.
    Kim, C. W.
    Yu, K. S.
    Shin, S. G.
    Jang, I. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S16 - S16
  • [26] ABSOLUTE ORAL BIOAVAILABILITY OF FIMASARTAN IN HEALTHY KOREAN ADULT MALE VOLUNTEERS.
    Choi, Y.
    Ghim, J.
    Sim, E.
    Park, S.
    Baek, S.
    Shin, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S37 - S37
  • [27] PHARMACOKINETIC/PHARMACODYNAMIC INTERACTIONS BETWEEN EVOGLIPTIN AND GLIMEPIRIDE IN HEALTHY MALE VOLUNTEERS.
    Yoo, H.
    Kim, Y.
    Sunwoo, J.
    Kim, Y.
    Lee, H.
    Jang, I. -J.
    Yu, K. -S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S55 - S55
  • [28] Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers
    C. Friedrich
    A. Ring
    T. Brand
    R. Sennewald
    E. U. Graefe-Mody
    H.-J. Woerle
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2011, 36 : 17 - 24
  • [29] Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers
    Friedrich, C.
    Ring, A.
    Brand, T.
    Sennewald, R.
    Graefe-Mody, E. U.
    Woerle, H. -J.
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2011, 36 (01) : 17 - 24
  • [30] PHARMACOKINETIC CHARACTERISTICS AND SAFETY OF β-LAPACHONE IN HEALTHY MALE VOLUNTEERS.
    Seong, S.
    Kang, W.
    Lee, J.
    Ohk, B.
    Kim, B.
    Gwon, M.
    Kim, H.
    Lee, H.
    Lee, I.
    Yoon, Y.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S89 - S89
12345